Treatment of malignant tumours with high doses of nitrogen mustard (TS 160) and-or high doses of ionizing radiation under the protection of autologous bone marrow (evaluation after a period of 7 years).
D001804:Blood Transfusion, Autologous; D001853:Bone Marrow; D001854:Bone Marrow Cells; D064987:Cell- and Tissue-Based Therapy; D006801:Humans; D007116:Immunization, Passive; D007275:Injections, Intravenous; D008134:Long-Term Care; D008722:Methods; D009369:Neoplasms / Q000532:radiotherapy / Q000628:therapy*; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage*; D011879:Radiotherapy Dosage
D009588:Nitrogen Mustard Compounds